GSMA Announces 2018 Global Mobile Awards Open for Entry
The GSMA today announced that the 2018 Global Mobile Awards (Glomo Awards) are now open for entry. The Glomo Awards honour the greatest achievements and innovations across the mobile industry, with 38 awards over eight categories. Entries for the 2018 awards will be accepted through Wednesday, 22 November 2017, with the winners announced at the GSMA Mobile World Congress taking place 26 February – 1 March 2018 in Barcelona.
“Mobile now connects two-thirds of the world’s population and is constantly evolving,” said Michael O’Hara, Chief Marketing Officer, GSMA. “Through the Glomo Awards, our industry will showcase the incredible innovation and creativity helping to keep us all connected now and in the future. We wish all entrants the best of luck.”
For 2018, the GSMA has refreshed the Glomo Award categories to reflect the changing shape of the mobile industry worldwide, and introduced new awards that highlight the most cutting-edge developments impacting the industry. The 2018 Glomo Awards will be presented within the following categories:
- Mobile Tech: This category will recognise the companies that are revolutionising the capabilities and reach of mobile and digital technologies. This category includes the coveted “Outstanding Mobile Technology Award (The CTOs’ Choice)”.
- Consumer: As consumers migrate to the connected age, this category will honour companies that have redefined the business-to-consumer relationship. Features include an award for “Best Overall Mobile Consumer Innovation (The Judges’ Choice)”.
- Fourth Industrial Revolution: This award category will distinguish key companies at the forefront of the digital shift, across seven market verticals. Highlights include a new award for “Best Mobile Innovation for Enterprise”, as well as the “Smart City Award (The Judges’ Choice)”, which will recognise the city authority that has raised the bar and embraced the Fourth Industrial Revolution.
- Device: This category has a strong reputation for recognising market leaders and celebrates achievements in hardware developments that are stimulating advances across the globe. For 2018, there will be a focus on new technologies that change how consumers interact with devices.
- Content & Media: This category will award the companies who are truly innovating and creating platforms that inform, educate and entertain everyone, everywhere. This category will showcase the imagination within this global trend with two new awards for “Best Mobile Game” and “Best Content and Media Innovation”.
- Social Good: ‘Creating a Better Future’ is the overarching theme for Mobile World Congress 2018, and this category underscores the mobile industry’s commitment to connecting everyone and everything to a better future. Awards in this category will honour the companies who are dedicated to this ideology and improving the lives of communities most in need.
- Government Excellence Awards: Traditionally, this award category honours governments that have fostered the true spirit of digitisation in their national agendas. This year, an additional award has been introduced to recognise the government that has pushed the boundaries of innovation.
- Outstanding Achievement: This category celebrates individuals and organisations that have made a remarkable contribution to the digital community.
Details on Entering the Glomo Awards
The Glomo Awards 2018 are open to companies across the entire mobile ecosystem and may be entered online; complete information on the Glomo Awards, including the full list of categories, award criteria and deadlines, can be found at www.mobileworldcongress.com/conference-programmes/global-mobile-awards-2018/ .
The awards will be judged by independent experts, analysts, journalists, academics, and, in some cases, mobile operator representatives. The winner of the “Outstanding Mobile Technology Award (The CTOs’ Choice)” will be selected by a panel of industry-leading CTOs from the worldwide operator community.
Select awards will be nominated by judges or by an independent panel of experts and will not be open for online entry. The submission of video to support entries is strongly encouraged by the awards judges. Entries for the Glomo Awards close on Wednesday, 22 November 2017 and the GSMA will announce the shortlist of nominations for each category by late January 2018.
Get Involved at Mobile World Congress 2018
For more information on Mobile World Congress 2018, including how to attend, exhibit or sponsor, visit www.mobileworldcongress.com. Follow developments and updates on Mobile World Congress on Twitter @GSMA using #MWC18, on our LinkedIn Mobile World Congress page https://www.linkedin.com/company/gsma-mobile-world-congress or on Facebook at https://www.facebook.com/mobileworldcongress/. For additional information on GSMA social channels, visit https://www.mobileworldcongress.com/networking/.
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.
For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31 | Pressemelding
Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00 | Pressemelding
AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20 | Pressemelding
AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11 | Pressemelding
The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other
Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20 | Pressemelding
Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to
Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31 | Pressemelding
Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom